Please login to the form below
life expectancy
This page shows the latest life expectancy news and features for those working in and with pharma, biotech and healthcare.
Your new goal for communications – social impact
The statistics make for stark reading. The pandemic has halted progress in health and shortened life expectancy, with reproductive, maternal and child health targets now reversed.
Latest news
-
Ipsen’s Sohonos approved by Health Canada
Once the bone is formed, the result is irreversible, leading to a loss of mobility and a shortened life expectancy.
-
NICE approval for Lilly's Verzenios is “fantastic news for thousands of women”
We also know from the clinical trial data that abemaciclib extends their life expectancy.”.
-
First NHS patient treated with Novartis’ SMA gene therapy Zolgensma
Children born with SMA type 1 typically have a life expectancy of around two years. ... Zolgensma is the latest example of the life-changing therapies that the NHS is now routinely using to transform the lives of patients and their families,” he added.
-
FDA approves expanded use for Chiesi’s sickle cell drug Ferriprox
In the US, SCD affects approximately 100, 000 people and is associated with a lower life expectancy of over 20 years compared with the general population. ... People who are living with SCD face significant challenges with pain and organ damage that can
-
New data for Recordati’s Isturisa reinforces benefit in Cushing’s disease
The normalisation of mUFC levels represents an ‘important’ treatment goal, Recordati said in a statement, by potentially reducing morbidity, improving quality of life and restoring life expectancy of patients with
More from news
Approximately 1 fully matching, plus 112 partially matching documents found.
Latest Intelligence
-
Tackling health equity demands tackling diversity and inclusion
And if you’re a man born in one of the most deprived areas in England, your life expectancy is nearly a decade shorter than if you were born in one
-
A new era for UK-Japanese scientific research relations
The connection with other major life sciences markets, such as the UK, is clear. ... In 1961, it established universal health insurance, it made huge advancements in the control and eradication of infectious diseases and, notably, it achieved the
-
The search for treatments for Parkinson’s disease
These drugs are effective and life expectancy is much higher than it was ten or 20 years ago. ... I think people living with Parkinson’s, and a lot of other conditions, will be very happy with two or more symptomatic treatments that improve their
-
Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
symptoms including bladder/ bowel dysfunction, high blood pressure and leukaemia, and can reduce life expectancy by up to 15 years.
-
Risks, reforms and rewards: the evolving Russian healthcare market
The period also saw male life expectancy fall, various diseases re-emerge and the suspension of immunisation programmes in various parts of the country. ... The increased spending had a positive impact on health metrics. By 2009, for example, life
More from intelligence
Approximately 0 fully matching, plus 25 partially matching documents found.
Latest from PMHub
-
How we’re empowering our teams to fight healthcare inequality
From lower life expectancy to racial disparities in maternal care and challenges accessing treatment, it’s clear people of color face barriers preventing them from fully benefiting from treatment and care ... Inequalities are often evident in the way
-
Sharing patient stories for World Pulmonary Hypertension Day
It’s a life-threatening disease that affects more than 75 million people globally. ... But if more people know about it and understand it, it can be diagnosed earlier and more accurately, in turn improving life expectancy.
-
WHITE PAPER: Why do men die younger?
3. Men were found, on average, to die approximately 6–8 years younger than their female counterparts and have a lower average life expectancy in all countries.
-
“Hard to reach” is no longer an acceptable excuse
According to the latest figures, people living in the UK can now expect to spend more years living in ill health compared to a decade ago and while life expectancy has
-
Rare Disease Day 2019: A patient perspective on primary sclerosing cholangitis
Living with PSC. Common symptoms, such as abdominal discomfort, itching, jaundice and fatigue, can make daily life with PSC very unpleasant. ... Life expectancy is also reduced, which is mostly dependent on the subsequent development of associated cancers
More from PMHub
Approximately 1 fully matching, plus 16 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- The patient voice – the value of patient-reported outcomes in HTA
- Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease
- Strategic commitment
- Pfizer set to acquire Global Blood Therapeutics in deal worth $5.4bn
- AstraZeneca and Daiichi Sankyo get FDA approval for breast cancer drug
- NHS England launches hepatitis C screening scheme to reach 2030 elimination goal
- Bayer’s Nubeqa receives FDA approval to treat metastatic prostate cancer
- Valneva and Pfizer initiate phase 3 Lyme disease vaccine study
- GSK’s ViiV and Medicines Patent Pool agree deal for HIV prevention
- GSK/Merck KGgA cancer drug fails in third trial
- Chiesi Group's Trimbow wins European licence
- Roche shares new positive Ocrevus data for MS patients
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Using behavioural psychology to improve patient recruitment
PMHub
Branding Science
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...
Latest intelligence
- Strategic commitment
- ...
- KOL Ambassador Program & Podcast Creation: A Customer Story
- ...
- Animation: Living With
- The journey from the patient's perspective...
